Revista gaucha de enfermagem · 2026
Intervening factors with HIV PrEP discontinuation: a scoping review.
Scoping ReviewСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gonçalves Junior Mauri, Paiva Karoline Silva, Matos Marcia Alves Dias de, Freires Ketllen Raiara Ferreira Santos, Guimarães Janaína Valadares, Sousa Fabiana Ribeiro, Matos Marcos André de
Аннотация
OBJECTIVE: To map scientific publications investigating the factors contributing to the discontinuation of PrEP use for HIV.
METHOD: This is a scoping review guided by the Joanna Briggs Institute. Between August and December 2025, searches were conducted in the following databases: Medline/PubMed; LILACS; Web of Science; EMBASE; CINAHL; BDENF via the Virtual Health Library; CAPES Theses and Dissertations Catalog; Digital Library of Theses and Dissertations; and Google Scholar. Finally, a reverse search was performed to identify possible additional works. The data were analyzed by numerical and thematic synthesis.
RESULTS: 869 studies were identified and, after selection, 21 studies from nine countries were analyzed. The processing resulted in five categories: sexual behaviors; stigma/prejudice; pharmacovigilance; access to health services; and vulnerabilities.
CONCLUSION: Studies from nine countries reveal common patterns, such as lower risk perception, adverse effects, and access barriers, as well as cultural influences and inequalities that amplify vulnerabilities. Thus, the factors contributing to PrEP discontinuation present a multifactorial complexity. Additionally, the absence of an operational parameter for the concept of PrEP discontinuation was observed, limiting more consistent analyses and more precise monitoring of these users, aiming at reducing avoidable seroconversion.
METHOD: This is a scoping review guided by the Joanna Briggs Institute. Between August and December 2025, searches were conducted in the following databases: Medline/PubMed; LILACS; Web of Science; EMBASE; CINAHL; BDENF via the Virtual Health Library; CAPES Theses and Dissertations Catalog; Digital Library of Theses and Dissertations; and Google Scholar. Finally, a reverse search was performed to identify possible additional works. The data were analyzed by numerical and thematic synthesis.
RESULTS: 869 studies were identified and, after selection, 21 studies from nine countries were analyzed. The processing resulted in five categories: sexual behaviors; stigma/prejudice; pharmacovigilance; access to health services; and vulnerabilities.
CONCLUSION: Studies from nine countries reveal common patterns, such as lower risk perception, adverse effects, and access barriers, as well as cultural influences and inequalities that amplify vulnerabilities. Thus, the factors contributing to PrEP discontinuation present a multifactorial complexity. Additionally, the absence of an operational parameter for the concept of PrEP discontinuation was observed, limiting more consistent analyses and more precise monitoring of these users, aiming at reducing avoidable seroconversion.